This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hywel C. Williams, MSc, FRCP, PhD

Arch Dermatol. 1997;133(11):1451-1452.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SIMPLE TOOLS for measuring disease severity for a range of dermatologic disorders are still limited. Currently, if we wish to record a change in disease severity for a person with an inflammatory dermatosis, we are constrained into using either complex, objective scales developed for clinical trials (eg, Psoriasis Area and Severity Index¹) or the other extreme, such as global rating by a dermatologist into mild, moderate, or severe categories. Clinical trial scales often take considerable time and training to use properly, and the clinical significance of a change in score from 34 to 26 may not always be apparent to consumers. Global rating by a dermatologist may appear to have better validity, but it is highly subjective and dependent on the viewpoint and background of the observer. There seems to be nothing in between for staging dermatologic disease severity. We need an instrument that is quick, easy to perform, . . . [Full Text PDF of this Article]

Author Affiliations
Queen's Medical Centre University Hospital Nottingham, England NG7 2UH

Footnotes
Reprints are available from the author.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?